{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:04:21Z","timestamp":1773795861685,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The molecular mechanism of opiate use promoting HIV-1 infection is not fully understood. TLR9 is expressed in many immune cells, including monocytes, macrophages, which can recognize viruses and viral products and consequently induce the production of antiviral factors and initiate immune responses. Previous studies have shown that chronic viral infections can overcome and impair TLR9 pathway. We aimed to explore whether opiate use enhances HIV infection through inhibition of TLR9 pathway via a population-based study. A total of 200 subjects were enrolled and divided into four groups as follows: Opiate+ HIV+\u2009(50), Opiate\u2212 HIV+\u2009(50), Opiate+ HIV\u2212 (50), and healthy control (Opiate\u2212 HIV\u2212, 50). All HIV-infected subjects did not receive antiretroviral therapy while they were enrolled in the study. The results showed that opiate use was associated with higher viral load and lower CD4+\u2009T cell count. Opiate use alone led to lower expression of TLR9, IRF7, and IFN-\u03b1 at the protein level in PBMCs. Combined with HIV-1 infection, opiate use resulted in lower expression of MyD88, ISG56, and MxA. In addition, morphine treatment promoted HIV-1 replication in macrophages via inhibition of TLR9 pathway. Our data reveal that opiate use plays a cofactor role in pathogenesis of HIV-1 infection through inhibition of TLR9 pathway.<\/jats:p>","DOI":"10.1038\/s41598-017-12066-3","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T13:32:33Z","timestamp":1507296753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Opiate use inhibits TLR9 signaling pathway in vivo: possible role in pathogenesis of HIV-1 infection"],"prefix":"10.1038","volume":"7","author":[{"given":"Yanyan","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiegang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"12066_CR1","unstructured":"UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. (Geneva, 2013)."},{"key":"12066_CR2","unstructured":"Commission, C. N. N. C. Report on drug control in China 2013. (Beijing, 2013)."},{"key":"12066_CR3","first-page":"145","volume":"44","author":"RM Donahoe","year":"1988","unstructured":"Donahoe, R. M. & Falek, A. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Advances in biochemical psychopharmacology \n                           44, 145\u2013158 (1988).","journal-title":"Advances in biochemical psychopharmacology"},{"key":"12066_CR4","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJM199212103272401","volume":"327","author":"PA Selwyn","year":"1992","unstructured":"Selwyn, P. A. et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. The New England journal of medicine \n                           327, 1697\u20131703, https:\/\/doi.org\/10.1056\/NEJM199212103272401 (1992).","journal-title":"The New England journal of medicine"},{"key":"12066_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00002030-199403000-00007","volume":"8","author":"PJ Ronald","year":"1994","unstructured":"Ronald, P. J., Robertson, J. R. & Elton, R. A. Continued drug use and other cofactors for progression to AIDS among injecting drug users. Aids \n                           8, 339\u2013343 (1994).","journal-title":"Aids"},{"key":"12066_CR6","doi-asserted-by":"publisher","first-page":"31305","DOI":"10.1074\/jbc.M001269200","volume":"275","author":"T MK BaumMiyagi","year":"2000","unstructured":"MK BaumMiyagi, T. et al. Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. The Journal of biological chemistry \n                           275, 31305\u201331310, https:\/\/doi.org\/10.1074\/jbc.M001269200 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"12066_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/QAI.0b013e3181900129","volume":"50","author":"MK Baum","year":"2009","unstructured":"Baum, M. K. et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Journal of acquired immune deficiency syndromes \n                           50, 93\u201399, https:\/\/doi.org\/10.1097\/QAI.0b013e3181900129 (2009).","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"12066_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/BF02532379","volume":"21","author":"S Roy","year":"1996","unstructured":"Roy, S. & Loh, H. H. Effects of opioids on the immune system. Neurochemical research \n                           21, 1375\u20131386 (1996).","journal-title":"Neurochemical research"},{"key":"12066_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11481-005-9009-8","volume":"1","author":"S Roy","year":"2006","unstructured":"Roy, S., Wang, J., Kelschenbach, J., Koodie, L. & Martin, J. Modulation of immune function by morphine: implications for susceptibility to infection. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology \n                           1, 77\u201389, https:\/\/doi.org\/10.1007\/s11481-005-9009-8 (2006).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"12066_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","volume":"6","author":"S Roy","year":"2011","unstructured":"Roy, S. et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. Journal of Neuroimmune Pharmacology \n                           6, 442\u2013465 (2011).","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"12066_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s001340050816","volume":"25","author":"H Georges","year":"1999","unstructured":"Georges, H. et al. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia. Intensive care medicine \n                           25, 198\u2013206 (1999).","journal-title":"Intensive care medicine"},{"key":"12066_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","volume":"6","author":"S Roy","year":"2011","unstructured":"Roy, S. et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology \n                           6, 442\u2013465, https:\/\/doi.org\/10.1007\/s11481-011-9292-5 (2011).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"issue":"Suppl 2","key":"12066_CR13","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1097\/00126334-200210012-00006","volume":"31","author":"A Nath","year":"2002","unstructured":"Nath, A. et al. Molecular basis for interactions of HIV and drugs of abuse. Journal of acquired immune deficiency syndromes \n                           31(Suppl 2), S62\u201369 (2002).","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"12066_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/00365540110080791","volume":"34","author":"G Quaglio","year":"2002","unstructured":"Quaglio, G., Lugoboni, F., Talamini, G., Lechi, A. & Mezzelani, P. Prevalence of tuberculosis infection and comparison of multiple-puncture liquid tuberculin test and Mantoux test among drug users. Scandinavian journal of infectious diseases \n                           34, 574\u2013576 (2002).","journal-title":"Scandinavian journal of infectious diseases"},{"key":"12066_CR15","first-page":"650","volume":"34","author":"L Bingyu","year":"2011","unstructured":"Bingyu, L. et al. Effect of Morphine on the re plication of HIV-1 in MT2 and macrophage. CHin J Lab Med \n                           34, 650\u2013655 (2011).","journal-title":"CHin J Lab Med"},{"key":"12066_CR16","first-page":"705","volume":"32","author":"L Bingyu","year":"2011","unstructured":"Bingyu, L. et al. Antiviral effect of lamivudine on HIV1 targeting MT2 cells influenced by morphine. Chin J Epidemiol \n                           32, 705\u2013708 (2011).","journal-title":"Chin J Epidemiol"},{"key":"12066_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00000542-199509000-00008","volume":"83","author":"MP Yeager","year":"1995","unstructured":"Yeager, M. P. et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology \n                           83, 500\u2013508 (1995).","journal-title":"Anesthesiology"},{"key":"12066_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031167","volume":"7","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Morphine suppresses IFN signaling pathway and enhances AIDS virus infection. Plos One \n                           7, e31167 (2012).","journal-title":"Plos One"},{"key":"12066_CR19","doi-asserted-by":"crossref","unstructured":"Liang, B. et al. Morphine Increases Lamivudine- and Nevirapine-Induced Human Immunodeficiency Virus-1 Drug-Resistant Mutations In Vitro. Microbial Drug Resistance (2016).","DOI":"10.1089\/mdr.2015.0347"},{"key":"12066_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature \n                           449, 819\u2013826, https:\/\/doi.org\/10.1038\/nature06246 (2007).","journal-title":"Nature"},{"key":"12066_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nature immunology \n                           5, 987\u2013995, https:\/\/doi.org\/10.1038\/ni1112 (2004).","journal-title":"Nature immunology"},{"key":"12066_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","volume":"173","author":"R Medzhitov","year":"2000","unstructured":"Medzhitov, R. & Janeway, C. Jr. Innate immune recognition: mechanisms and pathways. Immunological reviews \n                           173, 89\u201397 (2000).","journal-title":"Immunological reviews"},{"key":"12066_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2427(02)00228-3","volume":"91","author":"D Werling","year":"2003","unstructured":"Werling, D. & Jungi, T. W. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunop \n                           91, 1\u201312, https:\/\/doi.org\/10.1016\/S0165-2427(02)00228-3 (2003).","journal-title":"Vet Immunol Immunop"},{"key":"12066_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/aid.2013.0199","volume":"30","author":"M Buitendijk","year":"2014","unstructured":"Buitendijk, M., Eszterhas, S. K. & Howell, A. L. Toll-like receptor agonists are potent inhibitors of human immunodeficiency virus-type 1 replication in peripheral blood mononuclear cells. AIDS research and human retroviruses \n                           30, 457\u2013467, https:\/\/doi.org\/10.1089\/AID.2013.0199 (2014).","journal-title":"AIDS research and human retroviruses"},{"key":"12066_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int Immunol \n                           17, 1\u201314, https:\/\/doi.org\/10.1093\/intimm\/dxh186 (2005).","journal-title":"Int Immunol"},{"key":"12066_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.it.2010.07.004","volume":"31","author":"I Hirsch","year":"2010","unstructured":"Hirsch, I., Caux, C., Hasan, U., Bendriss-Vermare, N. & Olive, D. Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends in immunology \n                           31, 391\u2013397, https:\/\/doi.org\/10.1016\/j.it.2010.07.004 (2010).","journal-title":"Trends in immunology"},{"key":"12066_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3851\/IMP2762","volume":"19","author":"YW Huang","year":"2014","unstructured":"Huang, Y. W. et al. Reduced toll-like receptor 9 expression on peripheral CD14\u2009+\u2009monocytes of chronic hepatitis B patients and its restoration by effective therapy. Antiviral therapy \n                           19, 637\u2013643, https:\/\/doi.org\/10.3851\/IMP2762 (2014).","journal-title":"Antiviral therapy"},{"key":"12066_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11596-009-0310-2","volume":"29","author":"J Zhou","year":"2009","unstructured":"Zhou, J. et al. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. Journal of Huazhong University of Science and Technology. Medical sciences\u2009=\u2009Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban\u2009=\u2009Huazhong keji daxue xuebao. Yixue Yingdewen ban \n                           29, 313\u2013317, https:\/\/doi.org\/10.1007\/s11596-009-0310-2 (2009).","journal-title":"Medical sciences\u2009=\u2009Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban\u2009=\u2009Huazhong keji daxue xuebao. Yixue Yingdewen ban"},{"key":"12066_CR29","doi-asserted-by":"publisher","first-page":"11396","DOI":"10.1128\/JVI.02151-15","volume":"89","author":"L Pacini","year":"2015","unstructured":"Pacini, L. et al. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control. Journal of virology \n                           89, 11396\u201311405, https:\/\/doi.org\/10.1128\/JVI.02151-15 (2015).","journal-title":"Journal of virology"},{"key":"12066_CR30","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science \n                           303, 1529\u20131531, https:\/\/doi.org\/10.1126\/science.1093616 (2004).","journal-title":"Science"},{"key":"12066_CR31","unstructured":"McCluskie, M. & Krieg, A. In From innate immunity to immunological memory 155-178 (Springer, 2006)."},{"key":"12066_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026315","volume":"6","author":"IE Vincent","year":"2011","unstructured":"Vincent, I. E. et al. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. Plos One \n                           6, e26315 (2011).","journal-title":"Plos One"},{"key":"12066_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.it.2010.07.004","volume":"31","author":"I Hirsch","year":"2010","unstructured":"Hirsch, I., Caux, C., Hasan, U., Bendrissvermare, N. & Olive, D. Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends in Immunology \n                           31, 391\u2013397 (2010).","journal-title":"Trends in Immunology"},{"key":"12066_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester, S. N. & Li, K. Toll-like receptors in antiviral innate immunity. Journal of molecular biology \n                           426, 1246\u20131264 (2014).","journal-title":"Journal of molecular biology"},{"key":"12066_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/aid.2012.0200","volume":"29","author":"S Kaushik","year":"2013","unstructured":"Kaushik, S. et al. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. AIDS research and human retroviruses \n                           29, 501\u2013510, https:\/\/doi.org\/10.1089\/AID.2012.0200 (2013).","journal-title":"AIDS research and human retroviruses"},{"key":"12066_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.addr.2007.11.003","volume":"60","author":"JM Thompson","year":"2008","unstructured":"Thompson, J. M. & Iwasaki, A. Toll-like receptors regulation of viral infection and disease. Advanced drug delivery reviews \n                           60, 786\u2013794 (2008).","journal-title":"Advanced drug delivery reviews"},{"key":"12066_CR37","first-page":"132","volume":"31","author":"WF Pan Peijiang","year":"2015","unstructured":"Pan Peijiang, W. F. et al. Influence of Opiate Abuse on Expression of TLR9 mRNA among HIV-1-Infected Individuals. Chinese Journal of Virology \n                           31, 132\u2013137 (2015).","journal-title":"Chinese Journal of Virology"},{"key":"12066_CR38","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0002-9440(10)63476-1","volume":"163","author":"Y Li","year":"2003","unstructured":"Li, Y. et al. Morphine enhances hepatitis C virus (HCV) replicon expression. The American journal of pathology \n                           163, 1167\u20131175, https:\/\/doi.org\/10.1016\/S0002-9440(10)63476-1 (2003).","journal-title":"The American journal of pathology"},{"key":"12066_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11481-009-9149-3","volume":"4","author":"M Riazi","year":"2009","unstructured":"Riazi, M. et al. Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology \n                           4, 260\u2013275, https:\/\/doi.org\/10.1007\/s11481-009-9149-3 (2009).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"12066_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051387","volume":"7","author":"CK Mantri","year":"2012","unstructured":"Mantri, C. K., Pandhare Dash, J., Mantri, J. V. & Dash, C. C. Cocaine enhances HIV-1 replication in CD4+\u2009T cells by down-regulating MiR-125b. PloS one \n                           7, e51387, https:\/\/doi.org\/10.1371\/journal.pone.0051387 (2012).","journal-title":"PloS one"},{"key":"12066_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0192-0561(97)00017-9","volume":"19","author":"F Stoll-Keller","year":"1997","unstructured":"Stoll-Keller, F. et al. Effects of morphine on purified human blood monocytes. Modifications of properties involved in antiviral defences. International journal of immunopharmacology \n                           19, 95\u2013100 (1997).","journal-title":"International journal of immunopharmacology"},{"key":"12066_CR42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.7.4391","volume":"172","author":"JB Sundstrom","year":"2004","unstructured":"Sundstrom, J. B., Little, D. M., Villinger, F., Ellis, J. E. & Ansari, A. A. Signaling through Toll-Like Receptors Triggers HIV-1 Replication in Latently Infected Mast Cells. Journal of Immunology \n                           172, 4391 (2004).","journal-title":"Journal of Immunology"},{"key":"12066_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08820139.2011.561904","volume":"40","author":"N El-Hage","year":"2011","unstructured":"El-Hage, N., Podhaizer, E. M., Sturgill, J. & Hauser, K. F. Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunological investigations \n                           40, 498\u2013522 (2011).","journal-title":"Immunological investigations"},{"key":"12066_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T. & Akira, S. Signaling to NF-kappaB by Toll-like receptors. Trends in molecular medicine \n                           13, 460\u2013469, https:\/\/doi.org\/10.1016\/j.molmed.2007.09.002 (2007).","journal-title":"Trends in molecular medicine"},{"key":"12066_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell \n                           132, 344\u2013362, https:\/\/doi.org\/10.1016\/j.cell.2008.01.020 (2008).","journal-title":"Cell"},{"key":"12066_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.smim.2009.05.005","volume":"21","author":"S Manicassamy","year":"2009","unstructured":"Manicassamy, S. & Pulendran, B. Modulation of adaptive immunity with Toll-like receptors. Seminars in immunology \n                           21, 185\u2013193, https:\/\/doi.org\/10.1016\/j.smim.2009.05.005 (2009).","journal-title":"Seminars in immunology"},{"key":"12066_CR47","unstructured":"Takeshita, F. et al. In Seminars in immunology. 17\u201322 (Elsevier)."},{"key":"12066_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1189\/jlb.0809547","volume":"87","author":"S Hoshino","year":"2010","unstructured":"Hoshino, S. et al. HIV-1 Vpr induces TLR4\/MyD88-mediated IL-6 production and reactivates viral production from latency. Journal of leukocyte biology \n                           87, 1133\u20131143 (2010).","journal-title":"Journal of leukocyte biology"},{"key":"12066_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature \n                           434, 772\u2013777 (2005).","journal-title":"Nature"},{"key":"12066_CR50","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2353\/ajpath.2008.070971","volume":"172","author":"H Liang","year":"2008","unstructured":"Liang, H. et al. Methamphetamine enhances HIV infection of macrophages. American Journal of Pathology \n                           172, 1617\u20131624 (2008).","journal-title":"American Journal of Pathology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12066-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12066-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:54:02Z","timestamp":1671796442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12066-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12066"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12066-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"4 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13071"}}